Martin H. Dreyling, MD¹, Eva Hoster, PhD^2*, Achiel Van Hoof³, Bernd Metzner⁴, Christian Gisselbrecht⁵, Michael Pfreundschuh, MD, PhD⁶, Marcel Reiser^7*, Lorenz H. Truemper, MD, PhD⁸, Hjalmar Steinhauer^9*, Jean-Michel Boiron, MD, PhD¹⁰, Marc Boogaerts, MD, PhD¹¹, Vittorio Silingardi^12*, J.C. Kluin-Nelemans, MD, PhD¹³, Michael Unterhalt^14* and Wolfgang Hiddemann¹⁵

¹Medizinische Klinik III, Klinikum der Universitaet Muenchen-Grosshadern, Munich, Germany
²Medizinische Klinik III, Klinikum der Universitat Muenchen - Grosshadern, Munich, Germany
³A. Z. Sint Jan AV, Brugge, Belgium
⁴Klinikum Oldenburg, Oldenburg, Germany
⁵Dept. of Hematology, St. Louis Hospital, Paris, France
⁶Klinik f. Innere Medizin I, Homburg, Saar, Germany
⁷Klinikum, Universität zu Köln, Köln, Germany
⁸Dept. of Hem. and Onc., Georg August University, Gottingen, Germany
⁹Carl-Thiem-Klinikum, Cottbus, Germany
¹⁰EFS-AL, Bordeaux, Cedex, France
¹¹Hematology, U.Z. Gasthuisberg, Leuven, Belgium
¹²Dept. of Medical Oncology, University of Modena, Modena, Italy
¹³Hematology, University Medical Centre Groningen, Groningen, Netherlands
¹⁴Medizinische Klinik III, Klinikum der Universitaet Muenchen - Grosshadern, Munich, Germany
¹⁵III. Dept. of Internal Medicine, University of Munich, Munich, Germany

Thomas Gastinne^1*, Gandhi Damaj^2*, Thierry Lamy, PhD^3*, Norbert Ifrah^4*, Eric Deconinck⁵, Remy Gressin, MD⁶, Philippe Colombat, MD, PhD⁷, Vincent Delwail^8*, Christian Berthou^9*, Jean François Rossi^10*, Jean Luc Harousseau^11* and Noel-Jean Milpied, PhD¹²

¹CHU de Nantes, Nantes, France
²Groupe Francophone des Myelodysplasies (GFM), Bobigny, France
³Haematology, CHU Rennes, Rennes, France
⁴service Hématologie, CHU Angers,, Angers, France
⁵Hematology, INSERM UMR645 - CHU Jean Minjoz, Besançon
⁶Dept. of Onc.-Haem., CHU Michallon, Grenoble, France
⁷Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours, France
⁸Hématologie et Oncologie médicale, CHU Poitiers, Poitiers, France
⁹CHU Brest, Brest, France
¹⁰INSERM U847, Montpellier, France
¹¹Service d'Hématologie, CHU Hotel Dieu, Nantes, France, NAntes, France
¹²Hopital Haut Leveque - Pessac, Pessac, France

Christian Gisselbrecht¹, Olivier Fitoussi^2*, Karim Belhadj^3*, Nicolas Mounier, MD^4*, Pierre Feugier, MD^5*, Bertrand Coiffier⁶, Christian Recher, M.D;, Ph.D^7*, Olivier Casasnovas, MD^8*, Catherine Sebban, MD^9*, Christophe Ferme, MD^10*, Josette Briere^11*, Herve Tilly, MD¹² and Corinne Haioun¹³

¹Dept. of Hematology, St. Louis Hospital, Paris, France
²Oncologie, Polyclinique Bordeaux Nord, Bordeaux, France
³Service D'hématologie Clinique, Henri Mondor, Créteil, France
⁴CHU Nice, Nice, France
⁵CHU de Nancy - Hopital Brabois, Vandoeuvre les Nancy, France
⁶Centre Hospitalier Lyon-Sud, Pierre-Benite
⁷Service d'Hematologie, CHU Toulouse, Toulouse, France
⁸CHU Dijon, Dijon, France
⁹Hematology, centre Léon Bérard, Lyon, France
¹⁰Dept. of Medicine, Institut Gustave Roussy, Villejuif, France
¹¹Service d'onco-hématologie, Hôpital Saint-Louis APHP, INSERM U728 - Institut Universitaire d'Hématologie, Paris, France
¹²Centre Henri Becquerel, Rouen, France
¹³Service d'Hématologie Clinique, Hôpital Henri Mondor, Créteil, France

Wolfgang Hiddemann¹, Christian Buske, Dr^2*, Michael Kneba, MD, PhD³, Martin Dreyling⁴, Norbert Schmitz^5*, Eva Lengfelder^6*, Rudolf Schmits^7*, Marcel Reiser^8*, Bernd Metzner⁹ and Michael Unterhalt, PhD^10*

¹Third Department of Internal Medicine, University of Munic, Munich, Germany
²CCG Leukemia, Helmholtz Zentrum muenchen, Munich, Germany
³2nd Dept. of Internal Medicine, Univ. Schleswig-Holstein,, Kiel, Germany
⁴Department of Internal Medicine III, University Hospital of Munich, Großhadern, Munich, Germany
⁵Depatment of Hematology & Stem cell transplantation, Asclepios Clinic St. Georg, Hamburg, Germany
⁶Dept. of Hematology/Oncology, University of Heidelberg, Mannheim, Germany
⁷Hämatologie / Onkologie, Universitätsklinik Homburg, Homburg / Saar, Germany
⁸DSHNHL, Homburg, Saar, Germany
⁹Klinikum Oldenburg, Oldenburg, Germany
¹⁰Department of Internal Medicine III, University of Munich-Hospital Großhadern, Munich, Germany

Steven Le Gouill, MD, PhD^1*, Sophie De Guibert^2*, Christelle Volteau^3*, Marion Fournier^4*, Franck Morschhauser^5*, Chantal Doyen⁶, Pauline Brice⁷, Corinne Haioun^8*, Charles Foussard^9* and Gilles Andre Salles, MD, PhD¹⁰

¹Haematology, CHU Nantes, Nantes, France
²Hematology department, CHu de Rennes, Rennes, France
³Promotion de la recherche et statistiques, CHU de Nantes, Nantes, France
⁴Biostatistic department, Gelarc, Lyon, France
⁵Hematology, Centre Hospitalier Universitaire, Lille, France
⁶Hematology department, Université Catholique de Louvain, Louvain, Belgium
⁷Hopital Saint Louis
⁸Hopital Henri Mondor, Creteil, France
⁹Hematology, CHU d'Angers, Angers, France
¹⁰Hematologie, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

Maike Nickelsen, MD^1*, Carmen Canals Sr., MD^2*, Norbert Schmitz, MD, PhD¹, Charalampia Kyriakou, MD, PhD³, Monika Engelhardt, MD, PhD⁴, Thomas Relander, MD^5*, Werner Linkesch, MD, PhD^6*, Vladimir Koza, MD^7*, Giovanna Meloni, MD^8*, Armando Lopez-Guillermo, MD⁹, Karel Indrac, MD^10*, Dolores Caballero, MD^11*, Hannes Wandt, MD, PhD^12*, Niklas Theorin, MD^13*, Bertram Glass, MD, PhD^1* and Anna Sureda, Md, PhD^14*

¹Hematology and Stem Cell Transplantation, ASKLEPIOS Klinik St. Georg, Hamburg, Germany
²Lymphoma Working Party, EBMT, Barcelona, Spain
³Haematology, Nort West London NHS Trust, NPH Hospital, London, United Kingdom
⁴University Hospital, Freiburg, Germany
⁵Hematology, University Hospital, Lund, Sweden
⁶Med. Univ. Graz, Graz, Austria
⁷Dept. of Hematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic
⁸Division of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
⁹Hematology, Hospital Clinic, Barcelona, Spain
¹⁰Haemato-Oncology, University Hospital, Olomouc, Czech Republic
¹¹Hematology-BMT Unit, Hospital Clínico Salamanca
¹²Medical Department 5, Klinikum Nuernberg Nord, Nuernberg, Germany
¹³Dept. of Hematology, University Hospital, Linköping, Sweden
¹⁴Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Alison J. Moskowitz, MD¹, Stephen D. Nimer², Andrew D. Zelenetz, MD, PhD^3*, Tarun Kewalramani, MD^4*, Jill M Vanak, ACNP^5*, Jocelyn c Maragulia^5*, Joachim Yahalom, MD⁶ and Craig Moskowitz, MD⁷

¹Education and Training, Medical Oncology, New York, NY
²Laboratory of Molecular Aspects of Hematopoiesis, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan-Kettering Cancer Center, New York, NY
⁴Lahey Clinic, MA
⁵Medicine, MSKCC, NY, NY
⁶Memorial Sloan-Kettering Cancer Ctr., New York, NY
⁷Memorial Sloan Kettering Cancer Ctr., New York, NY

Craig H. Moskowitz, MD¹, Stephen D. Nimer², Andrew D. Zelenetz, MD, PhD^3*, Paul A. Hamlin Jr., MD³, Steven M. Horwitz, MD³, Ariela Noy, MD⁴, Carol S. Portlock, MD⁴, David J. Straus, MD⁵, John Gerecitano, MD, PhD⁶, Tarun Kewalramani, MD^7*, Jill M. Vanak, ACNP^8*, Jocelyn C. Maragulia^8* and Joachim Yahalom, MD⁴

¹Memorial Sloan Kettering Cancer Ctr., New York, NY
²Laboratory of Molecular Aspects of Hematopoiesis, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan-Kettering Cancer Center, New York, NY
⁴Memorial Sloan-Kettering Cancer Ctr., New York, NY
⁵Medicine, MSKCC, New York, NY
⁶Memorial Sloan-Kettering Cancer Ctr., Lymphoma Service, New York, NY
⁷Lahey Clinic, MA
⁸Medicine, MSKCC, NY, NY